Acquired resistance to anti-MAPK targeted therapy confers an immune-evasive tumor microenvironment and cross-resistance to immunotherapy in melanomaLisa Haas, Anna C. Obenauf, Tobias Neumann et al.|Nature Cancer|2021Cited by 196
Expression of the class 1 histone deacetylases HDAC8 and 3 are associated with improved survival of patients with metastatic melanomaJames S. Wilmott, Peter Hersey|Modern Pathology|2015Cited by 44
Objective assessment of tumor infiltrating lymphocytes as a prognostic marker in melanoma using machine learning algorithmsThazin Nwe Aung, David L. Rimm, Saba Shafi et al.|EBioMedicine|2022Cited by 33
Validation of an Accurate Automated Multiplex Immunofluorescence Method for Immuno-Profiling MelanomaZarwa Yaseen, James S. Wilmott|Frontiers in Molecular Biosciences|2022Cited by 30
Clinical Features Associated with Outcomes and Biomarker Analysis of Dabrafenib plus Trametinib Treatment in Patients with BRAF-Mutant Melanoma Brain MetastasesJames S. Wilmott, Michael A. Davies|Clinical Cancer Research|2022Cited by 16